NasdaqGS - Delayed Quote • USD
23andMe Holding Co. (ME)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 7:39 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 2 |
| Avg. Estimate | -0.15 | -0.22 | -1.1 | -0.67 |
| Low Estimate | -0.15 | -0.22 | -1.1 | -0.75 |
| High Estimate | -0.15 | -0.22 | -1.1 | -0.59 |
| Year Ago EPS | -0.14 | -0.23 | -0.69 | -1.1 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 1 | 2 | 2 |
| Avg. Estimate | 55.82M | 53.8M | 211.43M | 237.87M |
| Low Estimate | 49.74M | 53.8M | 205.35M | 212.24M |
| High Estimate | 61.9M | 53.8M | 217.5M | 263.5M |
| Year Ago Sales | 92.38M | 56.9M | 299.49M | 211.43M |
| Sales Growth (year/est) | -39.60% | -5.40% | -29.40% | 12.50% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -0.16 | -0.15 | -0.14 | -0.14 |
| EPS Actual | -0.14 | -0.23 | -0.16 | -0.16 |
| Difference | 0.02 | -0.08 | -0.02 | -0.02 |
| Surprise % | 12.50% | -53.30% | -14.30% | -14.30% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.15 | -0.22 | -1.1 | -0.67 |
| 7 Days Ago | -0.15 | -0.22 | -1.1 | -0.67 |
| 30 Days Ago | -0.15 | -0.2 | -1.1 | -0.61 |
| 60 Days Ago | -0.15 | -0.2 | -1.1 | -0.61 |
| 90 Days Ago | -0.11 | 0 | -0.73 | -0.49 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | ME | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -7.10% | -- | -- | 6.50% |
| Next Qtr. | 4.30% | -- | -- | 12.00% |
| Current Year | -59.40% | -- | -- | 5.30% |
| Next Year | 39.10% | -- | -- | 13.10% |
| Next 5 Years (per annum) | -- | -- | -- | 11.09% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | Citigroup: Neutral to Neutral | 4/16/2024 |
| Maintains | Citigroup: Buy to Buy | 8/10/2023 |
| Reiterates | Credit Suisse: Outperform to Outperform | 5/26/2023 |
| Maintains | Citigroup: Neutral to Neutral | 5/26/2023 |
| Initiated | Berenberg: Buy | 11/29/2022 |
| Maintains | Credit Suisse: Outperform | 11/8/2022 |
Related Tickers
TTOO T2 Biosystems, Inc.
2.8400
+3.65%
ISPC iSpecimen Inc.
0.2660
-5.07%
ILMN Illumina, Inc.
122.28
+1.02%
GH Guardant Health, Inc.
17.35
+1.11%
NVTAQ Invitae Corporation
0.0005
-94.44%
EXAS Exact Sciences Corporation
58.85
+0.10%
LAB Standard BioTools Inc.
2.4400
+3.39%
VNRX VolitionRx Limited
0.9137
+2.65%
APDN Applied DNA Sciences, Inc.
4.3700
-12.60%
TWST Twist Bioscience Corporation
31.54
+1.48%